Literature DB >> 22093382

Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation.

Eric S Weiss1, Jeremiah G Allen, Arman Kilic, Stuart D Russell, William A Baumgartner, John V Conte, Ashish S Shah.   

Abstract

BACKGROUND: No standard index based on donor factors exists for predicting mortality after orthotopic heart transplantation (OHT). We utilized United Network for Organ Sharing (UNOS) data to develop a quantitative donor risk score for OHT.
METHODS: We examined a prospectively collected open cohort of 22,252 patients who underwent primary OHT (1996 to 2007). Of the 284 donor-specific variables, those associated with 1-year (year) mortality (exploratory p-value < 0.2) were incorporated into a multivariate (MV) logistic regression model. The final model contained donor factors that improved the explanatory power (by pseudo-R2, area under the curve and likelihood ratio test). A quantitative donor risk score was created using odds ratios (ORs) from the final model. For external validity, a cross-validation strategy was employed whereby the score was generated using a randomly generated subset of cases (n = 17,788) and then independently validated on the remaining patients (n = 4,464).
RESULTS: A 15-point scoring system incorporated 4 variables: ischemic time; donor age; race mismatching; and blood urea nitrogen (BUN)/creatinine ratio. Derivation and validation cohort scores ranged from 1 to 15 and 1 to 12, respectively (mean 4.0 ± 2.1 for each). Each increase of 1 point increased the risk of 1-year death by 9% (OR = 0.09 [1.07 to 0.12]) in the derivation cohort and 13% (OR = 0.13 [1.08 to 0.18]) in the validation cohort (each p < 0.001). The odds of 1-year mortality by increments of 3 points were: 0 to 2 points (reference); 3 to 5 points (OR = 0.25 [1.12 to 0.40], p < 0.001); 6 to 8 pts (OR = 0.77 [1.56 to 2.02], p < 0.001); and 9 to 15 points (OR = 1.92 [1.54 to 2.39], p < 0.001). Donor risk score was predictive for 30-day mortality (OR = 0.11 [1.08 to 0.14], p < 0.001) and 5-year cumulative mortality (OR = 0.11 [1.09 to 0.13], p < 0.001).
CONCLUSIONS: We present a novel donor risk index for OHT predicting short- and long-term mortality. This donor risk score may prove valuable for donor heart allocation and prognosis after OHT. Copyright Â
© 2012 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22093382     DOI: 10.1016/j.healun.2011.10.004

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  30 in total

1.  Mitochondrial transplantation prolongs cold ischemia time in murine heart transplantation.

Authors:  Kamila Moskowitzova; Borami Shin; Kaifeng Liu; Giovanna Ramirez-Barbieri; Alvise Guariento; David Blitzer; Jerusha K Thedsanamoorthy; Rouan Yao; Erin R Snay; James A H Inkster; Arzoo Orfany; David Zurakowski; Douglas B Cowan; Alan B Packard; Gary A Visner; Pedro J Del Nido; James D McCully
Journal:  J Heart Lung Transplant       Date:  2018-09-28       Impact factor: 10.247

2.  Assessment of Heart Transplant Waitlist Time and Pre- and Post-transplant Failure: A Mixed Methods Approach.

Authors:  Benjamin A Goldstein; Laine Thomas; Jonathan G Zaroff; John Nguyen; Rebecca Menza; Kiran K Khush
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

Review 3.  Racial and ethnic disparities in outcomes after heart transplantation: A systematic review of contributing factors and future directions to close the outcomes gap.

Authors:  Alanna A Morris; Evan P Kransdorf; Bernice L Coleman; Monica Colvin
Journal:  J Heart Lung Transplant       Date:  2016-02-12       Impact factor: 10.247

4.  Donor selection in the modern era.

Authors:  Kiran K Khush
Journal:  Ann Cardiothorac Surg       Date:  2018-01

5.  How to obtain and maintain favorable results after heart transplantation: keys to success?

Authors:  Johan J A Van Cleemput; Tom O M Verbelen; Lucas N L Van Aelst; Filip R L Rega
Journal:  Ann Cardiothorac Surg       Date:  2018-01

6.  Impact of donor cardiac arrest on heart transplantation.

Authors:  Kevin W Southerland; Anthony W Castleberry; Judson B Williams; Mani A Daneshmand; Ayyaz A Ali; Carmelo A Milano
Journal:  Surgery       Date:  2013-08       Impact factor: 3.982

7.  Factors Associated With Short- and Long-term Liver Graft Survival in the United Kingdom: Development of a UK Donor Liver Index.

Authors:  David Collett; Peter J Friend; Christopher J E Watson
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

8.  Cardiac transplantation can be safely performed using selected diabetic donors.

Authors:  Sharven Taghavi; Senthil N Jayarajan; Lynn M Wilson; Eugene Komaroff; Jeffrey M Testani; Abeel A Mangi
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03-13       Impact factor: 5.209

9.  The Impact of Donor and Recipient Renal Dysfunction on Cardiac Allograft Survival: Insights Into Reno-Cardiac Interactions.

Authors:  Olga Laur; Meredith A Brisco; Alexander J Kula; Susan J Cheng; Abeel A Mangi; Lavanya Bellumkonda; Daniel L Jacoby; Steven Coca; W H Wilson Tang; Chirag R Parikh; Jeffrey M Testani
Journal:  J Card Fail       Date:  2015-11-23       Impact factor: 5.712

10.  Assessing Consequences of Intraaortic Balloon Counterpulsation Versus Left Ventricular Assist Devices at the Time of Heart Transplantation.

Authors:  Anthony W Castleberry; Adam D DeVore; Kevin W Southerland; James M Meza; William D Irish; Joseph G Rogers; Carmelo A Milano; Chetan B Patel
Journal:  ASAIO J       Date:  2016 May-Jun       Impact factor: 2.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.